ACT-128800 in Psoriasis

NCT00852670 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

66

Enrollment

INDUSTRY

Sponsor class

Conditions

Plaque Psoriasis

Interventions

DRUG: ACT-128800
DRUG: Placebo

Sponsor

Actelion